SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-02-002747
Filing Date
2002-05-15
Accepted
2002-05-15 17:12:59
Documents
6
Period of Report
2002-03-31

Document Format Files

Seq Description Document Type Size
1 THE MEDICINES COMPANY b43069mce10-q.txt 10-Q 89752
3 AMENDED & RESTATED EMPLMNT AGRMNT PEYTON MARSHALL b43069mcex10-1.txt EX-10.1 25466
4 STUDY AND EXCLUSIVE OPTION AGREEMENT b43069mcex10-2.txt EX-10.2 217294
5 SALES AND MARKETING DISTRIBUTION AGREEMENT b43069mcex10-3.txt EX-10.3 107202
6 LOAN AND SECURITY AGREEMENT b43069mcex10-4.txt EX-10.4 91866
7 AMENDMENT TO DEVELOPMENT & COMMERCIALIZATION AGMT b43069mcex10-5.txt EX-10.5 9411
  Complete submission text file 0000950135-02-002747.txt   543100
Mailing Address
Business Address ONE CAMBRIDGE CTR CAMBRIDGE MA 02142 6172259099
MEDICINES CO/ MA (Filer) CIK: 0001113481 (see all company filings)

IRS No.: 043324394 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31191 | Film No.: 02653688
SIC: 2834 Pharmaceutical Preparations